WatchRx, the First and Only Dedicated Smartwatch + SaaS Solution for Prescription Adherence, Selected by Bayer and TechCode for the Digital Healthcare Innovation Program


Boston, Mass. (June 12, 2018) – Bayer and TechCode have selected WatchRx for their first U.S. Digital Healthcare Program. WatchRx is the first and only dedicated smartwatch/SaaS solution with all-in-one medication reminders, built-in phone and GPS to support prescription adherence and to improve health outcomes for those managing complex medication regimens.
The Bayer-TechCode partnership is designed to accelerate digitally enabled advances in Pharmaceuticals. Seven start-ups were selected for the inaugural program which began in March of 2018 and culminates on June 15 with a Demo Day in Mountain View, Calif. On that day, WatchRx will present its pitch to an audience of investors as well as representatives from Bayer and TechCode.
Drug non-adherence costs the US economy a total of $290 Billion annually, including more than $100 Billion of avoidable hospitalizations. The challenge is most acute with patients managing multiple chronic conditions, which includes 75% of American seniors aged 65+. At least seven million people take 10+ medications a day.
The WatchRx IoT-health solution is a senior-friendly coordinated care platform that includes:
  • Hardware – a smartwatch with built-in phone and GPS combining visual medication reminders (name, prescription image, dosage) with customized voice instructions.
  • App – easy set-up medication schedule plus alerts for missed meds or spans with no patient movement.
  • SaaS – HIPAA-compliant back-end with 24/7 data on adherence and analytics providing insights healthcare providers need to make informed clinical decisions. (The cloud platform was recently profiled in a Google Customer Story.)
“Improved prescription compliance leads to improved health outcomes, slowing progression of conditions ranging from heart disease to Parkinson’s to diabetes,” said Jayanthi Narasimhan, founder and CEO. “We are honored that Bayer and TechCode see the value in WatchRx’s mission to help patients and consumers live healthier, more independent lives.”
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2017, the Group employed around 99,800 people and had sales of EUR 35.0 billion. Capital expenditures amounted to EUR 2.4 billion, R&D expenses to EUR 4.5 billion. For more information, go to
TechCode are focusing on incubator operation management and technology startup cultivation. TechCode is committed to building the world’s leading entrepreneurship ecosystem. Integrating a wide range of global resources, TechCode has established incubators in Beijing, Shanghai, Shenzhen, Guan, Silicon Valley, Seoul, Tel Aviv and Berlin to help get its startup members on their feet and grow rapidly. For more information, go to
WatchRx is an all-in-one medication reminder solution designed to meet the specific needs of both patients and their family and/or clinical care teams. Selected as the winner of the 2016 Boston Scientific/Google “Connected Patient Challenge,” the WatchRx team partners with hospitals, telehealth, home health agencies and more to improve the health of seniors and others with chronic conditions. Learn more at